Retinal prosthetic strategy with the capacity to restore normal vision

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 37, 2012, Pages 15012-15017

  Nirenberg, Sheila ^a   Pandarinath, Chethan ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Macular degeneration; Neural coding; Neural prosthetic; Retinal degeneration; Vision restoration

Indexed keywords

ARTICLE; CELL COUNT; CELL DENSITY; CELL STIMULATION; CONTROLLED STUDY; ENDOPROSTHESIS; IMAGE RECONSTRUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA GANGLION CELL; RETINA IMAGE; RETINA PROSTHESIS; STIMULUS RESPONSE;

ACTION POTENTIALS; ANIMALS; CROSSES, GENETIC; ELECTRIC STIMULATION; MICE; MICE, MUTANT STRAINS; RETINA; RETINAL DEGENERATION; RHODOPSIN; VISION, OCULAR; VISUAL PROSTHESIS;

EID: 84866276408     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1207035109     Document Type: Article

References (37)

1. Chopdar A, Chakravarthy U, Verma D (2003) Age related macular degeneration. BMJ 326:485-488.
2. Resnikoff S, Pascolini D, Mariotti SP, Pokharel GP (2008) in Bull World Health Organ 86(1):63-70.
3. Gordois A, Pezzullo L, Cutler H (2010) The Global Economic Cost of Visual Impairment (Access Economics Pty Limited, Canberra, Australia).
4. Chader GJ, Weiland J, Humayun MS (2009) Artificial vision: Needs, functioning, and testing of a retinal electronic prosthesis. Prog Brain Res 175:317-332.
5. Zrenner E, et al. (2009) Subretinal microelectrode arrays allow blind retinitis pigmentosa patients to recognize letters and combine them to words. Proc 2nd Int Conf IEEE Biomed Eng Inf, pp 1-4.
6. Winter JO, Cogan SF, Rizzo, JF, III (2007) Retinal prostheses: Current challenges and future outlook. J Biomater Sci Polym Ed 18:1031-1055.
7. Congdon N, et al.; Eye Diseases Prevalence Research Group (2004) Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122:477-485.
8. Loudin JD, et al. (2007) Optoelectronic retinal prosthesis: System design and performance. J Neural Eng 4:S72-S84.
9. Sekirnjak C, et al. (2008) High-resolution electrical stimulation of primate retina for epiretinal implant design. J Neurosci 28:4446-4456.
10. Bi A, et al. (2006) Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration. Neuron 50(1):23-33.
11. Lagali PS, et al. (2008) Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration. Nat Neurosci 11:667-675.
12. Tomita H, et al. (2009) Visual properties of transgenic rats harboring the channelrhodopsin-2 gene regulated by the thy-1.2 promoter. PLoS ONE 4:e7679.
13. Thyagarajan S, et al. (2010) Visual function in mice with photoreceptor degeneration and transgenic expression of channelrhodopsin 2 in ganglion cells. J Neurosci 30:8745-8758.
14. Greenberg KP, Pham A, Werblin FS (2011) Differential targeting of optical neuromodulators to ganglion cell soma and dendrites allows dynamic control of center-surround antagonism. Neuron 69:713-720.
15. Doroudchi MM, et al. (2011) Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness. Mol Ther 19:1220-1229.
16. Eckmiller R, Neumann D, Baruth O (2005) Tunable retina encoders for retina implants: why and how. J Neural Eng 2:S91-S104.
17. Nirenberg S (2011) Strategies for finding neural codes. Visual Population Codes, eds Kriegeskorte N, Kreiman G (MIT Press, Cambridge, MA).
18. Jacobs AL, et al. (2009) Ruling out and ruling in neural codes. Proc Natl Acad Sci USA 106:5936-5941.
19. Nagel G, et al. (2003) Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc Natl Acad Sci USA 100:13940-13945.
20. Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K (2005) Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 8:1263-1268.
21. Grimm C, et al. (2004) Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 24:5651-5658.
22. Hackam AS, et al. (2004) Identification of gene expression changes associated with the progression of retinal degeneration in the rd1 mouse. Invest Ophthalmol Vis Sci 45:2929-2942.
23. Nirenberg S, Pandarinath C, Ohiohenuan I (2011) Retina prosthesis. International Patent WO2011106783.
24. Dann JF, Buhl EH (1987) Retinal ganglion cells projecting to the accessory optic system in the rat. J Comp Neurol 262(1):141-158.
25. Quian Quiroga R, Panzeri S (2009) Extracting information from neuronal populations: Information theory and decoding approaches. Nat Rev Neurosci 10(3):173-185.
26. Kass RE, Ventura V, Brown EN (2005) Statistical issues in the analysis of neuronal data. J Neurophysiol 94:8-25.
27. Paninski L, Pillow J, Lewi J (2007) Statistical models for neural encoding, decoding, and optimal stimulus design. Prog Brain Res 165:493-507.
28. Giolli RA, Blanks RHI, Lui F (2006) The accessory optic system: Basic organization with an update on connectivity, neurochemistry, and function. Prog Brain Res 151:407-440.
29. Maguire AM, et al. (2008) Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 358:2240-2248.
30. Hauswirth WW, et al. (2008) Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther 19:979-990.
31. Cideciyan AV, et al. (2009) Vision 1 year after gene therapy for Leber's congenital amaurosis. N Engl J Med 361:725-727.
32. Simonelli F, et al. (2010) Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther 18:643-650.
33. Mancuso K, et al. (2009) Gene therapy for red-green colour blindness in adult primates. Nature 461:784-787.
34. Fitzgerald KM, Cibis GW, Giambrone SA, Harris DJ (1994) Retinal signal transmission in Duchenne muscular dystrophy: Evidence for dysfunction in the photoreceptor/depolarizing bipolar cell pathway. J Clin Invest 93:2425-2430.
35. Cibis GW, Fitzgerald KM (2001) The negative ERG is not synonymous with night-blindness. Trans Am Ophthalmol Soc 99:171-175, discussion 175-176.
36. Fine I (2008) The effects of visual deprivation. Artificial Sight, eds Humayun MS, Weiland JD, Chader G, Greenbaum E (Springer, New York), pp 47-70.
37. Baseler HA, et al. (2011) Large-scale remapping of visual cortex is absent in adult humans with macular degeneration. Nat Neurosci 14:649-655.